Sigyn Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of amortization expense expected to be recognized in remainder of fiscal year following latest fiscal year ended for present value of future profits of insurance contract acquired in business combination.

No definition available.

Name:	us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseRemainderOfFiscalYear
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Amount of amortization expense expected to be recognized during next fiscal year following latest fiscal year for present value of future profits of insurance contract acquired in business combination.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 805
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6918812&loc=d3e30762-158568

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Name:	us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Amount of amortization expense expected to be recognized during third fiscal year following latest fiscal year for present value of future profits of insurance contract acquired in business combination.

Name:	us-gaap_PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Amount of amortization expense expected to be recognized during second fiscal year following latest fiscal year for present value of future profits of insurance contract acquired in business combination.